课题基金 / 基金详情

Role of pre- and postsynaptic mu opioid receptors in antinociception and tolerance

Role of pre- and postsynaptic mu opioid receptors in antinociception and tolerance
突触前和突触后μ阿片受体在镇痛和耐受中的作用
批准号:
9107437
负责人:
Susan L Ingram
金额:
$19.06万
依托单位国家:
美国
项目类别:
财政年份:
2015
资助国家:
美国
项目状态:
已结题
起止时间:
2015-08-01 至 2018-07-31

项目摘要

项目成果

Susan L Ingram的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
 DESCRIPTION (provided by applicant): Morphine and other opioids are extremely effective therapeutic drugs for treating pain, but their antinociceptive effects are limited by detrimental side effects with continued administration, including opioid-induced hyperalgesia, tolerance and dependence. Currently, over $8.6 billion a year are spent in the U.S. for health, work, and legal issues associated with the use and abuse of prescription opioids. The mechanisms underlying these side effects and opioid-induced synaptic plasticity have been difficult to elucidate, primarily because we have a rudimentary understanding of how endogenous pain control systems are activated and regulated by the brain. It is known that presynaptic mu opioid receptors (MOPrs) on GABAergic terminals in the periaqueductal gray area (PAG) activate the descending antinociceptive pathway to the spinal cord. However, MOPrs are also abundantly expressed in the soma and dendrites of PAG neurons and the role of these postsynaptic receptors is not known. We hypothesize that the postsynaptic MOPrs are responsible for the adaptations in opioid tolerance. The proposed studies will test this hypothesis with selective knock-down of the postsynaptic MOPrs using in vivo administration of siRNA constructs. Specific Aim #1 will test whether knock-down of the postsynaptic MOPrs attenuates morphine-induced antinociception. Specific Aim #2 will determine if antinociception can be rescued to normal levels in morphine tolerant rats that have received the siRNA pretreatment. We expect that these studies will confirm that postsynaptic MOPrs regulate the gain of the descending pain modulatory circuit and are appropriate targets for analgesic therapies that do not induce detrimental side-effects such as hyperalgesia, tolerance and dependence with long-term administration. The studies will also lay the groundwork for an R01 application focused on understanding the molecular mechanisms of postsynaptic MOPr regulation of the endogenous descending pain modulatory circuit.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Role of lateral habenula in methamphetamine TAAR1-mediated synaptic plasticity and aversion
  • 批准号:
    10733665
  • 项目类别:
  • 资助金额:
    $56.56万
  • 财政年份:
    2023
  • 负责人:
    Susan L Ingram
  • 依托单位:
Dendritic DAT activity monitored with fluorescent biosensors
  • 批准号:
    7795252
  • 项目类别:
  • 资助金额:
    $31.09万
  • 财政年份:
    2008
  • 负责人:
    Susan L Ingram
  • 依托单位:
Dendritic DAT activity monitored with fluorescent biosensors
  • 批准号:
    7524822
  • 项目类别:
  • 资助金额:
    $31.15万
  • 财政年份:
    2008
  • 负责人:
    Susan L Ingram
  • 依托单位:
Dendritic DAT activity monitored with fluorescent biosensors
  • 批准号:
    7628408
  • 项目类别:
  • 资助金额:
    $30.52万
  • 财政年份:
    2008
  • 负责人:
    Susan L Ingram
  • 依托单位:
海外基金